Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review

被引:2
|
作者
Xu, Xiaoxiao [1 ]
Zhang, Le [1 ]
Wang, Yafei [1 ]
Zhang, Qing [1 ]
Zhang, Lianyu [2 ]
Sun, Baocun [2 ]
Zhang, Yizhuo [1 ]
机构
[1] Tianjin Med Univ Canc Inst & Hosp, Dept Hematol, Tianjin Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China
[2] Tianjin Med Univ, Dept Pathol, Tianjin Key Lab Canc Prevent & Therapy, Tianjin Canc Hosp & Inst, Tianjin 300060, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2013年 / 6卷 / 04期
关键词
Double hit; follicular lymphoma; MYC; BCL2; BCL6; cases report; B-CELL LYMPHOMA; POOR-PROGNOSIS; C-MYC; CLINICAL PRESENTATION; TRANSLOCATIONS; REARRANGEMENT; T(14/18); CYTOGENETICS; FEATURES; GENE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Double-hit or triple-hit B-cell lymphomas (DHL and THL) are rare subtype lymphomas usually associated with poor prognosis. It is defined by two or three recurrent chromosome translocations; MYC/8q24 loci, usually in combination with the t (14; 18) (q32; q21) bcl-2 gene or/and BCL6/3q27 chromosomal translocation. DHL was often observed both in de-novo diffuse large B cell lymphomas (DLBCL). It is otherwise unclassifiable, showing features intermediate that of large B-cell lymphoma and Burkitt lymphoma. Here, we present two follicular lymphoma patients; one transformed to THL, another transformed to DHL. Both cases revealed aggressive clinical courses with poor prognosis and associated with acquisition of c-Myc gene (MYC) and central nervous system (CNS) involvement. We reviewed the related literature, correlated the immunophenotype and clinical manifestations such as response to therapy and prognosis. Although the incidence of DHT and THL is low, cytogenetic and FISH analyses should be included when B-cell lymphoma patients experience relapse or refractory course of disease. We concluded that c-Myc may contribute to aggressive transformation, and more mechanism-based therapy should be explored.
引用
收藏
页码:788 / 794
页数:7
相关论文
共 47 条
  • [31] A Combined Biomarker of Bright CD38 and MYC ≥55% Is Highly Predictive of Double-/Triple-Hit High-Grade B-Cell Lymphoma Implication on Diagnostic Workup
    Alsuwaidan, Abdullah
    Koduru, Prasad
    Fuda, Franklin
    Jaso, Jesse Manuel
    Chen, Mingyi
    Rosado, Flavia
    Luu, Hung S.
    Sweed, Nathan
    Garcia, Rolando
    Doucet, Meggie
    Desai, Neil B.
    Kumar, Kiran A.
    Awan, Farrukh T.
    Geethakumari, Praveen Ramakrishnan
    Chen, Weina
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 158 (03) : 338 - 344
  • [32] SPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-/triple-hit status
    Croci, G. A.
    Au-Yeung, R. K. H.
    Reinke, S.
    Staiger, A. M.
    Koch, K.
    Oschlies, I
    Richter, J.
    Poeschel, V
    Held, G.
    Loeffler, M.
    Trumper, L.
    Rosenwald, A.
    Ott, G.
    Spang, R.
    Altmann, B.
    Ziepert, M.
    Klapper, W.
    ANNALS OF ONCOLOGY, 2021, 32 (11) : 1400 - 1409
  • [33] Histiocytic/dendritic cell sarcoma arising from follicular lymphoma involving the bone: a case report and review of literature
    Zhang, Da
    McGuirk, Joseph
    Ganguly, Siddhartha
    Persons, Diane L.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (04) : 529 - 532
  • [34] Identification of "Double Hit" Lymphomas Using Updated WHO Criteria: Insights From Routine MYC Immunohistochemistry in 272 Consecutive Cases of Aggressive B-Cell Lymphomas
    Sakr, Hany
    Cook, James R.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (06) : 410 - 415
  • [35] A Case of Advanced Primary Thyroid Double-Hit B Cell Lymphoma in Which Complete Remission has been Maintained After High-Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation Performed During the Second Remission, with a Review of the Literature
    Sekiguchi, Yasunobu
    Shimada, Asami
    Imai, Hidenori
    Wakabayashi, Mutsumi
    Sugimoto, Keiji
    Nakamura, Noriko
    Sawada, Tomohiro
    Ohta, Yasunori
    Komatsu, Norio
    Noguchi, Masaaki
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2014, 30 : S166 - S173
  • [36] Histiocytic/dendritic cell sarcoma arising from follicular lymphoma involving the bone: a case report and review of literature
    Da Zhang
    Joseph McGuirk
    Siddhartha Ganguly
    Diane L. Persons
    International Journal of Hematology, 2009, 89 : 529 - 532
  • [37] Stage IV follicular lymphoma (Grade II) arising from skeletal muscle - a case report and literature review
    Zahid, Naila Anjum
    Tabassum, Sobia
    Ashraf, Syed Mohammad Mushtaq
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2013, 63 (08) : 1049 - 1052
  • [38] A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit A position paper from the Italian Group of Haematopathology (GIE)
    Di Napoli, Arianna
    Remotti, D.
    Agostinelli, C.
    Ambrosio, M. R.
    Ascani, S.
    Carbone, A.
    Facchetti, F.
    Lazzi, S.
    Leoncini, L.
    Lucioni, M.
    Novero, D.
    Pileri, S.
    Ponzoni, M.
    Sabattini, E.
    Tripodo, C.
    Zarno, A.
    Paulli, M.
    Ruco, L.
    VIRCHOWS ARCHIV, 2019, 475 (04) : 513 - 518
  • [39] Double Hit Ph-Negative Adult B-ALL Patients with MYC and BCL2 Rearrangements and CDKN2A Genetic Abnormalities Have Poor Clinical Outcomes: Report of Two Cases
    Chung, Betty
    Miller, Tara
    Hao, Suyang
    Zieske, Arthur
    Ewton, April
    Zu, Youli
    Huh, Yang
    Pingali, Sai Ravi
    Iyer, Swaminathan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S188 - S189
  • [40] Double-Hit Lymphoma Demonstrating t(6;14;18)(p25;q32;q21), Suggesting Two Independent Dual-Hit Translocations, MYC/BCL-2 and IRF4/BCL-2
    Tabata, Rie
    Yasumizu, Ryoji
    Tabata, Chiharu
    Kojima, Masaru
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2013, 53 (02) : 141 - 150